Search - tctmd.com

Displaying 1 - 20 of 51

Sort: Relevancy | Date

News Conference News ESC 2025

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

Michael O'Riordan

September 10, 2025

News Conference News ESC 2024

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

Michael O'Riordan

September 09, 2024

News Conference News ESC 2024

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

Michael O'Riordan

September 01, 2024

News Conference News ESC 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Michael O'Riordan

September 06, 2023

News Daily News ESC 2023

Dietary Nitrate Dramatically Cuts Contrast-Induced Nephropathy: NITRATE-CIN

Michael O'Riordan

August 30, 2023

News Conference News ESC 2023

Routine ECMO in AMICS Patients Not Protective: ECLS-SHOCK

Caitlin E. Cox

August 26, 2023

News Conference News ESC 2023

FIRE: Complete Revascularization Best Even for Elderly Patients With MI

Michael O'Riordan

August 26, 2023

News Conference News ESC 2022

CV Care Around Noncardiac Surgery: New ESC Guidelines

Michael O'Riordan

September 07, 2022

News Conference News ESC 2022

GRACE 3.0: Women With NSTE ACS Get a Boost From Updated Score

Caitlin E. Cox

September 06, 2022

News Conference News ESC 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

L.A. McKeown

August 30, 2022

News Conference News ESC 2022

Less Death, Major Bleeding With Transradial Access: Meta-analysis

Michael O'Riordan

August 29, 2022

News Conference News ESC 2022

‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR

Shelley Wood

August 28, 2022

News Conference News ESC 2022

Polypill Bests Usual Care in Patients With Recent MI: SECURE

Michael O'Riordan

August 26, 2022

News Conference News ESC 2021

OAC Analysis From MASTER DAPT Raises No Red Flags for Shorter DAPT

Shelley Wood

September 02, 2021

News Conference News ESC 2021

No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER

Michael O'Riordan

September 02, 2021

News Conference News ESC 2021

Both Acute and Chronic Myocardial Injury in COVID-19 Impede 6-Month Survival

Caitlin E. Cox

September 01, 2021

News Conference News ESC 2021

Studies Reveal Surprising Benefits of Smoking Cessation and ‘Greenness’

L.A. McKeown

August 28, 2021

News Daily News ESC 2021

Colchicine in STEMI Fails to Reduce Infarct Size: COVERT-MI

Caitlin E. Cox

August 26, 2021

News Conference News ESC 2020

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

Caitlin E. Cox

September 03, 2020

News Conference News ESC 2019

BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI

Caitlin E. Cox

September 10, 2019

Advertisement

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Dietary Nitrate Dramatically Cuts Contrast-Induced Nephropathy: NITRATE-CIN

Routine ECMO in AMICS Patients Not Protective: ECLS-SHOCK

FIRE: Complete Revascularization Best Even for Elderly Patients With MI

CV Care Around Noncardiac Surgery: New ESC Guidelines

GRACE 3.0: Women With NSTE ACS Get a Boost From Updated Score

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

Less Death, Major Bleeding With Transradial Access: Meta-analysis

‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR

Polypill Bests Usual Care in Patients With Recent MI: SECURE

OAC Analysis From MASTER DAPT Raises No Red Flags for Shorter DAPT

No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER

Both Acute and Chronic Myocardial Injury in COVID-19 Impede 6-Month Survival

Studies Reveal Surprising Benefits of Smoking Cessation and ‘Greenness’

Colchicine in STEMI Fails to Reduce Infarct Size: COVERT-MI

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content